胆酸成分的改变是抗生素诱导的肝损伤的可能危险因素
Akinori Takemura1, Shotaro Suminoe1, Tomoya Hirai1
1Laboratory of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University.
The Journal of toxicological sciences
|August 3, 2025
概括
抗生素可以通过改变胆汁酸来引起药物诱导性肝损伤 (DILI). 这项研究表明,在小鼠模型中,高合胆酸,特别是陶罗胆酸 (TCA),与DILI相关.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 微生物学 微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 药物诱导性肝损伤 (DILI) 是一个重要的临床问题,通常是严重的和可能致命的.
- 抗生素经常与引起DILI有关.
- 驱动抗生素诱导的肝损伤的精确机制仍然不完全理解.
研究的目的:
- 调查抗生素引起的胆酸成分变化有助于肝损伤的假设.
- 建立和验证一种小鼠模型,用于研究抗生素诱导的肝损伤.
主要方法:
- 开发一种小鼠模型,用于抗生素诱导的肝损伤.
- 单独使用或与胆酸 (CA) 结合使用特定抗生素 (万科米辛,克素,安培素).
- 测量肝损伤标志物,包括氨酸转胺酶 (ALT) 和血陶罗胆酸 (TCA) 水平.
主要成果:
- 与胆酸一起服用的抗生素显著增加了ALT水平,表明肝损伤.
- 在血TCA水平升高和ALT升高之间观察到强烈的正相关性.
- 这项研究成功地模拟了抗生素诱导的肝损伤.
结论:
- 血中结合胆酸水平升高,以增加的TCA为例,与诱导DILI有关.
- 抗生素使用后胆酸代谢的改变,可能是由于肠道细菌的破坏,是抗生素诱导的肝损伤的关键因素.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
225
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
225
Hepatic Drug Excretion: Enterohepatic Cycling
1.8K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.8K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
873
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
873
Hepatic Drug Clearance: Role of Transporters
101
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
101
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
375
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
375
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K


